Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Therapeutics CEO Acquires 6,000 Shares In Co

Feb 29 (Reuters) - Nykode Therapeutics ASA  NYKD.OL :
    * PRIMARY INSIDER MICHAEL ENGSIG, CHIEF EXECUTIVE OFFICER OF
NYKODE THERAPEUTICS ASA, HAS TODAY ACQUIRED 6,000 SHARES IN
NYKODE THERAPEUTICS ASA AT A PRICE OF NOK 16.71 PER SHARE
    * FOLLOWING TRANSACTION, MICHAEL ENGSIG HOLDS 15,850 SHARES
IN
NYKODE THERAPEUTICS ASA

Source text for Eikon:  ID:nObifDWFKa 
Further company coverage:  NYKD.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on Nykode Therapeutics ASA

See all news